VRTX
Vertex Pharmaceuticals
Description:
Vertex Pharmaceuticals, Inc. is a leading biopharmaceutical company headquartered in Boston, Massachusetts, specializing in the development and commercialization of innovative therapies for serious diseases, particularly in cystic fibrosis (CF). With a robust portfolio of approved therapies leveraging its proprietary scientific expertise, Vertex has transformed the treatment landscape for CF patients, underscoring its commitment to addressing unmet medical needs. The company continues to focus on research and development initiatives, aiming to expand its pipeline into new therapeutic areas and maintain its position as a frontrunner in the biopharmaceutical industry. Vertex's dedication to innovation, combined with strong financial performance, positions it well for sustained growth and value creation in the evolving healthcare market.
Address:
50 NORTHERN AVENUE, BOSTON, MA, UNITED STATES, 02210
Fiscal year end:
December
Market capitalization:
$103 Billion
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
+276%
How much will you get:
$3,761
Prices dates:
30-09-2015: $104.14 and 30-09-2025: $391.64